Psychedelic-Assisted Therapy
Therapeutic breakthroughs with guided medicine journeys
Gabriel can help you find the right clinic and decide if this is a fit before you book.
During the visit
Comprehensive screening and preparation sessions
Discussion of intentions and therapeutic goals
Dosing session in comfortable, safe clinical environment
6-8 hours with trained therapists present throughout
Duration
6-8 hour dosing session plus prep and integration
Starting at
$1,500
Practitioner access
Ask Gabriel
Category
Mind-Body
About this treatment
What this treatment is designed to do
Psychedelic-Assisted Therapy combines the use of psychedelic substances (such as psilocybin, MDMA, or ketamine) with psychotherapy to treat mental health conditions that have been resistant to conventional treatments. After decades of prohibition, psychedelic research has experienced a renaissance, with FDA-designated breakthrough therapy status for MDMA-assisted therapy for PTSD and psilocybin therapy for treatment-resistant depression. These substances appear to create windows of neuroplasticity and emotional openness that, when combined with skilled therapeutic support, allow for profound healing and perspective shifts.
Psychedelic experiences in therapeutic settings are carefully structured with extensive preparation, a supported dosing session, and integration therapy afterward. The substances are administered in controlled clinical environments with trained therapists present throughout. Rather than the recreational "trip," therapeutic psychedelic experiences are intentional journeys into consciousness with the goal of healing trauma, resolving depression, reducing anxiety, or confronting existential distress. The experience often involves insights, emotional releases, mystical or transcendent states, and new perspectives on long-held patterns.
Currently, legal access to psychedelic-assisted therapy is limited. Ketamine-assisted therapy is available through specialized clinics (ketamine is legal for off-label use). MDMA and psilocybin are available only through clinical trials or, in some locations, through newly emerging legal frameworks. The therapy is not for everyone and requires careful screening, but for appropriate candidates with treatment-resistant conditions, the results can be remarkable. Many people describe single sessions as equivalent to years of traditional therapy in terms of insights gained and healing achieved.
Visit flow
What happens during the session
Comprehensive screening and preparation sessions
Discussion of intentions and therapeutic goals
Dosing session in comfortable, safe clinical environment
6-8 hours with trained therapists present throughout
Music, eyeshades, and supportive presence during experience
Possible intense emotions, insights, or mystical states
Multiple integration therapy sessions afterward to process experience
Best for
Why people usually choose this
People with treatment-resistant depression or PTSD
Those with severe anxiety, especially end-of-life distress
Individuals who haven't responded to conventional treatments
People seeking deep psychological and spiritual healing
Key outcomes
What people hope to improve
Potential rapid relief from treatment-resistant depression
Breakthrough healing for PTSD and trauma
Reduced anxiety, especially existential distress in terminal illness
Enhanced emotional openness and self-compassion
Gabriel intelligence
How Gabriel makes this treatment more actionable
Treatment fit
Root-cause context before you book
Gabriel can help decide whether psychedelic-assisted therapy fits your symptoms, labs, and recovery goals before you spend money on a session.
Protocol pairing
Connect sessions to a real plan
Gabriel can pair this with diagnostics, supplements, peptides, and follow-up cadence so it fits into a real protocol instead of sitting in isolation.
Practitioner match
Find the right clinic, not just the nearest one
Gabriel uses trust, treatment fit, and modality overlap to surface practitioners who are more likely to be a strong match for this exact treatment path.
Evidence & safety
What to know before committing
Psychedelic-assisted therapy has strong and growing research support. Recent clinical trials show remarkable efficacy for PTSD (MDMA) and depression (psilocybin). When administered in proper clinical settings with screening and support, psychedelics are surprisingly safe physiologically. Psychological risks require careful screening for psychosis risk. This is not recreational use, it's medical treatment requiring professional oversight. Access is currently limited but expanding. A promising frontier in mental health treatment.
Related treatments
Similar treatments people compare next
Use these when you want adjacent options in the same category before deciding what to book.
Not sure if this treatment is the right next move?
Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.